FDA Inspection
Fenwal International, Inc.Fenwal International, Inc. – FDA Inspection, Feb 2, 2009
Record Details
This FDA Inspection record concerns Fenwal International, Inc., with an inspection on February 2, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Fenwal International, Inc.
- Inspection Date
- February 2, 2009
- Product Type
- Drugs
View Company Profile
ID · 1ad37a57-765b-4bd7-90b0-c5c23699f523
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 562861
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fenwal International, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | San Juan District Office | Blood and Blood Products |
| September 18, 2024 | VAI | San Juan District Office | Blood and Blood Products |
| September 24, 2022 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 24, 2021 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2019 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Fenwal International, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.